Eruptive melanocytic nevi in human immunodeficiency virus infection. 1991

I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar

UI MeSH Term Description Entries
D008297 Male Males
D009508 Nevus, Pigmented A nevus containing melanin. The term is usually restricted to nevocytic nevi (round or oval collections of melanin-containing nevus cells occurring at the dermoepidermal junction of the skin or in the dermis proper) or moles, but may be applied to other pigmented nevi. Nevus, Melanocytic,Nevi, Melanocytic,Nevi, Pigmented,Pigmented Moles,Melanocytic Nevi,Melanocytic Nevus,Pigmented Nevi,Pigmented Nevus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015819 Substance Abuse, Intravenous Abuse, overuse, or misuse of a substance by its injection into a vein. Drug Abuse, Intravenous,Drug Abuse, Parenteral,Intravenous Drug Abuse,Intravenous Substance Abuse,Parenteral Drug Abuse

Related Publications

I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
March 1989, Archives of dermatology,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
March 2017, Expert opinion on drug metabolism & toxicology,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
October 2017, Actas dermo-sifiliograficas,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
January 1998, Klinische Padiatrie,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
October 2019, American journal of clinical dermatology,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
November 2018, JAAD case reports,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
November 2016, Journal of dermatological case reports,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
August 1997, Journal of the American Academy of Dermatology,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
February 2022, Melanoma research,
I Betlloch, and C Amador, and E Chiner, and F Pasquau, and J L Calpe, and A Vilar
January 2024, International journal of dermatology,
Copied contents to your clipboard!